Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: Association with insulin resistance and type 2 diabetes;Insulinorésistance et diabète de type 2 dans une population afro-caribéenne infectée par le VIH : association aux concentrations plasmatiques d'adiponectine et de leptine

Diabetes and Metabolism

Volumn 37, Issue 2, 2011, Pages 98-104

  Deloumeaux, J ^a,b   Maachi, M ^c   Sow Goerger, M T ^b   Lamaury, I ^b   Velayoudom, F L ^b   Cheret, A ^b   Batard, M L ^b   Muller, P ^b   Bastard, J P ^c,d   Chene, G ^e   Capeau, J ^c,d   Foucan, L ^a,b  

^a UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^b CHU de Pointe a Pitre   (Guadeloupe)

^c HÔPITAL TENON   (France)

^d CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^e INSERM   (France)

Author keywords

Adiponectin; Afro Caribbean; HIV infection; Insulin resistance; Leptin; Pathophysiology; Type 2 diabetes

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ABDOMINAL OBESITY; ADULT; AFRICAN CARIBBEAN; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GUADELOUPE; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL;

EID: 79955062133     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.07.009     Document Type: Article

References (27)

1. Christeff N., Lortholary O., Casassus P., Thobie N., Dalle M.T., Veyssier P., et al. Serum lipid concentration with reference to the clinical and immunological status of HIV infected men. Ann Med Interne (Paris) 1995, 146:490-495.
2. Saves M., Raffi F., Capeau J., Rozenbaum W., Ragnaud J.M., Perronne C., et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 2002, 34:1396-1405.
3. Wohl D.A., McComsey G., Tebas P., Brown T.T., Glesby M.J., Reeds D., et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis 2006, 43:645-653.
4. Ledergerber B., Furrer H., Rickenbach M., Lehmann R., Elzi L., Hirschel B., et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 2007, 45:111-119.
5. Haque W.A., Shimomura I., Matsuzawa Y., Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002, 87:2395.
6. Vigouroux C., Maachi M., Nguyen T.H., Coussieu C., Gharakhanian S., Funahashi T., et al. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS 2003, 17:1503-1511.
7. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
8. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003, 52:239-243.
9. Ferris W.F., Naran N.H., Crowther N.J., Rheeder P., van der Merwe L., Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005, 37:695-701.
10. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The Evidence Report. Obes Res 1998;6(Suppl. 2):51-209S.
11. WHO. Definition, Diagnosis and Classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva: World Health Organization, 1999.
12. Brown T.T., Cole S.R., Li X., Kingsley L.A., Palella F.J., Riddler S.A., et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005, 165:1179-1184.
13. Kusnik-Joinville O., Weill A., Salanave B., Ricordeau P., Allemand H. Treated diabetes: what trends between 2000 and 2005?. Prat Organ Soins 2007, 38:1-12.
14. Jean-Baptiste E.D., Larco P., Charles-Larco N., Vilgrain C., Simon D., Charles R. Glucose intolerance and other cardiovascular risk factors in Haiti. Prevalence of Diabetes and Hypertension in Haiti (PREDIAH). Diabetes Metab 2006, 32:443-451.
15. Boullu-Sanchis S., Lepretre F., Hedelin G., Donnet J.P., Schaffer P., Froguel P., et al. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab 1999, 25:150-156.
16. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
17. Thomas T., Burguera B., Melton L.J., 3rd, Atkinson E.J., O'Fallon W.M., et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000, 49:1278-1284.
18. Ruhl C.E., Everhart J.E., Ding J., Goodpaster B.H., Kanaya A.M., Simonsick E.M., et al. Serum leptin concentrations and body adipose measures in older black and white adults. Am J Clin Nutr 2004, 80:576-583.
19. Mittendorfer B. Insulin resistance: sex matters. Curr Opin Clin Nutr Metab Care 2005, 8:367-372.
20. Aboud M., Elgalib A., Kulasegaram R., Peters B. Insulin resistance and HIV infection: a review. Int J Clin Pract 2007, 61:463-472.
21. Bastard J.P., Caron M., Vidal H., Jan V., Auclair M., Vigouroux C., et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002, 359:1026-1031.
22. Mynarcik D.C., Combs T., McNurlan M.A., Scherer P.E., Komaroff E., Gelato M.C. Adiponectin and leptin levels in HIV-Infected subjects with insulin resistance and body fat redistribution. JAIDS 2002, 31:514-520.
23. Wauters M., Considine R.V., Yudkin J.S., Peiffer F., De Leeuw I., Van Gaal L.F. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003, 35:92-96.
24. Inoue M., Maehata E., Yano M., Taniyama M., Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005, 54:281-286.
25. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
26. Seino Y., Hirose H., Saito I., Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007, 56:1493-1499.
27. Hara K., Horikoshi M., Yamauchi T., Yago H., Miyazaki O., Ebinuma H., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29:1357-1362.